—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Guardant Health Inc (GH) — Technical state

As of 2026-11-02 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 44 out of 100 (momentum 87 · quality 18 · valuation 11), as of 2026-11-03.
  • Signal: Uptrend stack intact — Trades +0.6% vs the 50-day and +30.5% vs the 200-day average, 10.6% below the 52-week high and +129% off the 52-week low. Computed from daily closes. (as of 2026-11-02)
  • Trend: Guardant Health Inc trades 0.6% above its 50-day and 30.5% above its 200-day moving average. (as of 2026-11-02)

Guardant Health develops blood and tissue tests that detect and monitor cancer, using DNA fragments shed by tumours into the bloodstream. Its main products profile tumour mutations for treatment choices, track cancer recurrence after treatment, and screen adults for colorectal cancer through a blood draw rather than a colonoscopy.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the GH overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Uptrend stack intact

Trades +0.6% vs the 50-day and +30.5% vs the 200-day average, 10.6% below the 52-week high and +129% off the 52-week low. Computed from daily closes.

The moving-average stack

Continue: the GH chart & overview · quality & forensics · the earnings record · the signal board

FAQ · from the current data · as of 2026-11-02

Quick answers

What is the current Closelooknet signal on GH?

Uptrend stack intact — Trades +0.6% vs the 50-day and +30.5% vs the 200-day average, 10.6% below the 52-week high and +129% off the 52-week low. Computed from daily closes. As of 2026-11-02; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is GH above its 50-day and 200-day moving averages?

As of 2026-11-02, Guardant Health Inc trades +0.6% above its 50-day and +30.5% above its 200-day average, with the 20-day +1.3% away.

How far is GH from its 52-week high?

10.6% below the 52-week high and 129% above the 52-week low, as of 2026-11-02.

Related in the Closelooknet universe

then Diagnostics & Research. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.